Also, over-expression of TRIM28 is associated with poor outcome in GM patients [24], while TRIM52 controls cell cycle with a reduced proliferation speed and a compromised cycle progression in U87MG and A172 glioblastoma (GBM) cell lines [26]. This evidence concerns the gene TRIM52 and glioblastoma.